Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Kwok-Cheung Lung et al.|The Lancet|2020Cited by 1.6k
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome SequencingKelvin Kai‐Wang To, Kwok‐Yung Yuen, Carol Ho-Yan Fong et al.|Clinical Infectious Diseases|2020Cited by 818
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptomsXin Li, Kwok‐Yung Yuen, Jasper Fuk‐Woo Chan et al.|Infection|2020Cited by 50